Sinus Cancer
Symptoms, Doctors, Treatments, Advances & More

Sinus Cancer Overview

Save information for later
Sign Up

Learn About Sinus Cancer

What is the definition of Sinus Cancer?
Sinus cancer is a rare disease in which malignant cells form in the tissues of the paranasal sinuses (small hollow spaces around the nose) and the nasal cavity. While sinus cancer can form in any of the different types of paranasal sinuses, it usually first appears in the maxillary sinus. Causes of sinus cancer include exposure to particular workplace chemicals or dust, an infection with human papilloma virus (HPV), and smoking, with an increased risk for males over 40.
What are the symptoms of Sinus Cancer?
Symptoms include persistent sinus congestion or obstruction, pain, swelling of the face, eyes, or ears, tearing from the eyes, loss of vision, decreased sense of smell, tooth pain, frequent nosebleeds, fatigue, weight loss, or a facial or neck lump.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Sinus Cancer?
Treatments for sinus cancer include surgery, radiation, chemotherapy, or a combination.
Who are the top Sinus Cancer Local Doctors?
Carl H. Snyderman
Elite in Sinus Cancer
Dr. Carl H. Snyderman
Otolaryngology
Elite in Sinus Cancer
Dr. Carl H. Snyderman
Otolaryngology

University Ear Nose And Throat Specialists

203 Lothrop Street, Suite 300, 
Pittsburgh, PA 
412-647-2100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Carl H. Snyderman, MD, is a professor in the department of otolaryngology at the University of Pittsburgh School of Medicine and codirector of the UPMC Center for Skull Base Surgery. He specializes in otolaryngology-head and neck surgery, and cranial base surgery. Dr. Snyderman is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. His top areas of expertise are Cerebrospinal Fluid Leak, Olfactory Neuroblastoma, Sinus Cancer, Endoscopy, and Nerve Decompression.

Elite in Sinus Cancer
Dr. Nithin D. Adappa
Otolaryngology
Elite in Sinus Cancer
Dr. Nithin D. Adappa
Otolaryngology

Penn Pituitary Center

3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nithin Adappa is an Otolaryngologist in Philadelphia, Pennsylvania. Dr. Adappa is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. His top areas of expertise are Cerebrospinal Fluid Leak, Sinusitis, Sinus Cancer, Endoscopy, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Adappa is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Sinus Cancer
Dr. Derrick T. Lin
Otolaryngology
Elite in Sinus Cancer
Dr. Derrick T. Lin
Otolaryngology

Mass Eye And Ear, Otolaryngology?Head And Neck Surgery

243 Charles Street, 
Boston, MA 
617-573-3502
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Derrick Lin is an Otolaryngologist in Boston, Massachusetts. Dr. Lin is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. His top areas of expertise are Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, Sinus Cancer, Laryngectomy, and Glossectomy.

View All Doctors
What are the latest Sinus Cancer Clinical Trials?
Phase 1/1b Study of AKT Inhibitor Ipatasertib With Chemoradiation for Locally Advanced Head and Neck Cancer
Phase 1/1b Study of AKT Inhibitor Ipatasertib With Chemoradiation for Locally Advanced Head and Neck Cancer
Who is this study for: Patients with locally advanced head and neck cancer
Enrollment Status: Recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Radiation
Study Drugs: Cisplatin, Ipatasertib
Study Phase: Phase 1

Summary: This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy (chemo-radiation) in patients with head and neck cancer. Ipatasertib is in a class of medications called protein kinase B (AKT) inhibitors. It may stop the growth of tumor cells and may kill them. Cisplatin, which is a chemotherapy ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Integrated Cancer Repository for Cancer Research
Integrated Cancer Repository for Cancer Research
Enrollment Status: Recruiting
Publish Date: January 22, 2026

Summary: The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rur...

View All Clinical Trials